| Autor: |
N. Jumez, Laurent Henry, P.-E. Stoebner, Thierry Lavabre-Bertrand, P. Roger, Jean Martinez, L. Le Gallic, Olivier Coux, G. Garcin, Laurent Meunier |
| Rok vydání: |
2011 |
| Předmět: |
|
| Zdroj: |
British Journal of Dermatology. 165:311-320 |
| ISSN: |
0007-0963 |
| DOI: |
10.1111/j.1365-2133.2011.10447.x |
| Popis: |
Summary Background Deregulation of the proteasome pathway has been shown to be involved in the pathogenesis of several inflammatory disorders. To date limited information exists on proteasome and immunoproteasome expression and activity in psoriasis skin. Objectives To investigate the potential role of proteasomes in the pathogenesis of psoriasis. Methods Thirty-six patients with psoriasis and 40 healthy subjects were included. The protein and mRNA expression levels and proteolytic activity of proteasome and immunoproteasome subunits were determined using immunohistochemistry, quantitative polymerase chain reaction and fluorogenic peptide substrate in lesional and nonlesional psoriasis skin. We additionally measured the plasmatic proteasome (p-proteasome) levels using enzyme-linked immunosorbent assay. Results We reveal an increased expression of proteasome and immunoproteasome subunits but stable mRNA levels in lesional psoriasis skin as compared with nonlesional psoriasis skin (n = 19), suggesting that proteasome and immunoproteasome expression is regulated post-transcriptionally. This proteasome overexpression was associated with a significant increase of the proteasomal chymotrypsin-like activity that was threefold higher in lesional skin than in nonlesional skin (n = 3). p-Proteasome levels were enhanced in patients with psoriasis (mean ± SEM 3960 ± 299 ng mL−1, range 1484–8987) when compared with controls (2535 ± 187 ng mL−1, range 654–6446, P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Plný text